ArticleEJHaem2023

Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse-risk acute myeloid leukaemia: A single-centre retrospective analysis.

Bao-Quan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.